Salena Zito

New York Post / Washington Examiner / CNN

Guest

Salena Zito is a columnist for the New York Post, a reporter for the Washington Examiner and a contributor to CNN. She is the author of the forthcoming book The Great Divide, about the populist tribes in Rust Belt counties that voted for Obama and Trump.

Salena Zito on KCRW

President Trump says he might appoint a new FBI Director before his first overseas trip starts on Friday.

What's next for the FBI… and the GOP?

President Trump says he might appoint a new FBI Director before his first overseas trip starts on Friday.

from To the Point

More from KCRW

Four years after protesters called to defund the police, voters worried about crime are poised to toss out a reformer D.A. and pass a tough-on-crime bill.

from KCRW Features

Did voters learn anything new from the Trump-Harris debate? Are live fact checks useful or fair? Plus, disinformation muddies the discourse on immigration.

from Left, Right & Center

Will shifts in the Democratic agenda leave progressives out in the cold? KCRW discusses the DNC. Plus, can labor laws for minors balance safety and opportunity?

from Left, Right & Center

Tune in as NPR and CBS News offers live coverage of the Vice Presidential debate.

KCRW provides an election outlook with a week to go. Can the electorate stop being driven by hate? Plus, what was the Washington Post’s real mistake?

from Left, Right & Center

In the midst of election season, conversations revolving around the levers of power become more frequent, and in the case of a U.S.

from Scheer Intelligence

The genocide in Gaza has brought the issue of Israel — and what it represents for Jewish people — into the forefront of Jewish communities worldwide.

from Scheer Intelligence

City Councilman Kevin De Leon is running for reelection against tenant rights attorney Ysabel Jurado. The outcome could determine whether City Hall leans more progressive.

from KCRW Features

The Irvine Police Department purchased a Tesla Cybertruck to promote its D.A.R.E drug program. But some taxpayers say the money should be spent elsewhere.

from KCRW Features